Invesaro

Stocks Health care SLGL

NASDAQ · Health care

Sol-Gel Technologies Ltd. (SLGL)

Sol-Gel Technologies Ltd. reported revenue of $19.4M in fiscal 2025, up 68.0% from a year earlier. It posted a net loss of $6.1M. Operating cash flow minus capital spending left $275K of free cash flow in fiscal 2025. At December 31, 2025 it held $11M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 19, 2026.

Revenue (FY2025)
$19.4M
+68.0% year on year
Net margin
-31.6%

What Sol-Gel Technologies Ltd. does

Sol-Gel Technologies Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SLGL.

Revenue and profit by year

Revenue
FY18: $129K $129K FY18FY19: $22.9M $22.9M FY19FY20: $8.8M $8.8M FY20FY21: $31.3M $31.3M FY21FY22: $3.9M $3.9M FY22FY23: $1.6M $1.6M FY23FY24: $11.5M $11.5M FY24FY25: $19.4M $19.4M FY25
Net income
FY18: -$32.2M -$32.2M FY18FY19: -$24.6M -$24.6M FY19FY20: -$29.3M -$29.3M FY20FY21: $3.2M $3.2M FY21FY22: -$14.9M -$14.9M FY22FY23: -$27.2M -$27.2M FY23FY24: -$10.6M -$10.6M FY24FY25: -$6.1M -$6.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$19.4M-$7.5M-$6.1M-$2.19$275K
2024$11.5M-$12M-$10.6M-$3.79-$13.9M
2023$1.6M-$29.3M-$27.2M-$10.01-$17.9M
2022$3.9M-$16.2M-$14.9M-$6.44-$9.7M
2021$31.3M$3M$3.2M$1.39-$7.8M
2020$8.8M-$30.2M-$29.3M-$12.88-$25.7M

Latest SEC filings

What Sol-Gel Technologies Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 17, 2026
  2. August 20, 2026
  3. June 9, 2026
  4. May 28, 2026
  5. May 6, 2026
  6. April 15, 2026
  7. March 31, 2026
  8. March 24, 2026
  9. March 24, 2026
  10. March 23, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 14, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SLGL

What does Sol-Gel Technologies Ltd. do?

Sol-Gel Technologies Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SLGL.

Is Sol-Gel Technologies Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $6.1M on revenue of $19.4M.

How much revenue does Sol-Gel Technologies Ltd. make?

In fiscal 2025 Sol-Gel Technologies Ltd. reported revenue of $19.4M. That is 68.0% more than a year earlier.

When did Sol-Gel Technologies Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 19, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 17, 2026.

Similar companies

Follow SLGL

Get an email when Sol-Gel Technologies Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SLGL: get an email when it files

Where the numbers come from

Financial figures are the values Sol-Gel Technologies Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.